Rchr
J-GLOBAL ID:200901057430319957   Update date: Apr. 04, 2024

Yoshida Kiyotsugu

ヨシダ キヨツグ | Yoshida Kiyotsugu
Affiliation and department:
Job title: Porfessor
Research field  (1): Tumor biology
Papers (85):
  • Eriko Harada, Saishu Yoshida, Yuta Imaizumi, Akira Kawamura, Takashi Ohtsuka, Kiyotsugu Yoshida. Dual-specificity tyrosine-regulated kinase 2 exerts anti-tumor effects by induction of G1 arrest in lung adenocarcinoma. Biochimica et biophysica acta. General subjects. 2024. 1868. 6. 130600-130600
  • Chika Nakagawa, Tsunekazu Oikawa, Kohji Yamada, Akihito Tsubota, Chisato Saeki, Kuniko Katagiri, Naoko Tago, Hiroshi Kamioka, Kaoru Ueda, Koichiro Haruki, et al. Protein kinase C delta enhances the diagnostic performance of hepatocellular carcinoma. Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals. 2024. 1-13
  • Yasuhiro Takano, Satomi Yogosawa, Yuta Imaizumi, Hiroshi Kamioka, Yumi Kanegae, Ken Eto, Kiyotsugu Yoshida. DYRK2 promotes chemosensitivity via p53-mediated apoptosis after DNA damage in colorectal cancer. Cancer science. 2023
  • Hiroshi Kamioka, Satomi Yogosawa, Tsunekazu Oikawa, Daisuke Aizawa, Kaoru Ueda, Chisato Saeki, Koichiro Haruki, Masayuki Shimoda, Toru Ikegami, Yuji Nishikawa, et al. Dyrk2 gene transfer suppresses hepatocarcinogenesis by promoting the degradation of Myc and Hras. JHEP reports : innovation in hepatology. 2023. 5. 7. 100759-100759
  • Kohji Yamada, Yoshito Hannya, Tsunekazu Oikawa, Ayano Yoshida, Kuniko Katagiri, Saishu Yoshida, Rei Koizumi, Naoko Tago, Yuya Shimoyama, Akira Kawamura, et al. Extended-Synaptotagmin 1 Enhances Liver Cancer Progression Mediated by the Unconventional Secretion of Cytosolic Proteins. Molecules (Basel, Switzerland). 2023. 28. 10
more...
MISC (30):
more...
Lectures and oral presentations  (37):
  • 大腸がんに対するアデノウイルスベクターによるDYRK2過剰発現を用いた新規遺伝子治療
    (日本外科学会定期学術集会抄録集 2021)
  • 肝臓癌におけるDYRK2の強制発現はアポトーシスを介して抗腫瘍効果を発揮する
    (東京慈恵会医科大学雑誌 2019)
  • DNA Methylation of Dual-Specificity Tyrosine-Regulated Kinase 2 (DYRK2) Promoter Regulates Proliferation of Human Colorectal Cancer
    (JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS 2019)
  • DYRK2のメチル化を標的とした大腸癌治療の可能性
    (日本消化器外科学会総会 2019)
  • DYRK2のプロモーター領域のメチル化はヒトの結腸直腸癌の進行を制御する(DNA methylation of DYRK2 promoter regulates progression of human colorectal cancer)
    (日本癌学会総会記事 2018)
more...
Education (2):
  • 1993 - 1997 東京慈恵会医科大学大学院 医学研究科博士課程
  • 1987 - 1993 東京慈恵会医科大学 医学部
Work history (6):
  • 2012/04 - 現在 Jikei University Dept. of Biochemistry Professor
  • 2007/04 - 2012/03 Tokyo Medical and Dental University Medical Research Institute
  • 2005/12 - 2007/03 Tokyo Medical and Dental University Medical Research Institute
  • 2002/07 - 2005/11 Tokyo Medical and Dental University Medical Research Institute
  • 2000/10 - 2002/06 Dana Farber Cancer Institute Instructor
Show all
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page